Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 371 results for "kexin"

Renal soluble PRR and LXR [Medical Sciences]

Xiaohan Lu a , b , c , 1 , Fei Wang c , a , b , 1 , Chuanming Xu c , Sunny Soodvilai a , b , Kexin Peng a , b , c , Jiahui Su c , Long Zhao a , b , Kevin T. Yang a , b , Yumei Feng d , e , Shu-Feng Zhou f , Jan-Åke Gustafsson g , 2 , and ... PNAS, 4 weeks ago

Methylation of p53 in Spalax sympatric speciation [Evolution]

Yang Zhao a , b , c , d , Jia-Wei Tang a , Zhi Yang a , Yi-Bin Cao a , e , Ji-Long Ren a , Yuval Ben-Abu f , Kexin Li d , g , Xue-Qun Chen a , b , c , 1 , Ji-Zeng Du a , b , c , 1 , and Eviatar Nevo d , 1 a Division of Neurobiology and ...
 PNAS2 months ago

Address by Minister Li Kexin at the T20 Conference

Brookings Institute, Washington D.C. Mr. Chair, Distinguished Guests, Ladies and Gentlemen, It's a great honor to be invited to this special event. As one of the most important engagement groups of G20, T20 is such an effective platform ...
 China Embassy1 week ago

EFFICACY AND SAFETY OF PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9 INHIBITORS TREATMENT IN FAMILIAL HYPERCHOLESTEROLEMIA: A COMPREHENSIVE META-ANALYSIS OF ALL RANDOMIZED CLINICAL TRIALS

Note: Since your browser does not support Javascript, you must press the Continue button once
 Journal of the American College of Cardiology3 weeks ago Replacing statins with PCSK9-inhibitors and delaying treatment until 18 years of age in patients with familial hypercholesterolaemia is not a good idea  European Heart Journal4 weeks ago Circulating Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Predicts Future Risk of Cardiovascular Events Independently of Established Risk Factors [Epidemiology and Prevention]  Circulation1 month ago PCSK9 Monoclonal Antibodies Show Promise in ACS  Physician's Briefing1 month ago
[x]  

Minister Li Kexin Attended "Chinese Cultural Night" at theMeridian International Center

Minister Li Kexin Attended "Chinese Cultural Night" at the Meridian International Center 2016/02/05 Red lanterns and Chinese knots made the Meridian House festive in the evening of Feb. 4th, when Chinese Cultural Night co-hosted by the ...
 China Embassy2 months ago

Pfizer completes patient enrollment in bococizumab SPIRE-2 cardiovascular outcome trial

Pfizer has completed patient enrollment in the global SPIRE-2 cardiovascular outcome trial for its investigational agent bococizumab. SPIRE-2 is evaluating the efficacy and safety of bococizumab compared to placebo in reducing the risk of major ...
 Pharmaceutical Business Review1 day ago Pfizer Announces Patient Enrollment Completion In SPIRE-2 Cardiovascular Trial  Quotenet.com2 days ago Bococizumab SPIRE-2 Cardiovascular Outcome Study Fully Enrolled  Wallstreet Online2 days ago Pfizer completes patient enrolment in bococizumab SPIRE-2 cardiovascular outcome study  Drug Development Technology1 day ago
[x]  

Amgen,Astellas announce the launch of Repatha in Japan

Singapore: Japanese pharma giant Amgen Astellas BioPharma and Astellas Pharma recently announced the launch of their product- Repatha inhibitor syringe in the Japanese market. The genetically recombined injection that consists of a proprotein ...
 Bio Spectrum Asia14 hours ago Amgen Astellas launches Repatha in Japan25-04-2016  Pharma Letter3 days ago

PCSK9 Association With Lipoprotein(a) [Brief UltraRapid Communication]

1 * , Devon C Christian 1 , Jessica Minnier 2 , Deanna Plubell 1 , Michael D Shapiro 1 , Calvin Yeang 3 , Ilaria Giunzioni 1 , Mikaël Croyal 4 , P B Duell 1 , Gilles Lambert 5 , Sotirios Tsimikas 3 and Sergio Fazio 1 1 Knight ...
 Circulation Research17 hours ago

Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences

Figure1 Via downregulation of the lipoprotein lipase (LPL) adapter molecule GPIHP-1 and upregulation of the LPL inhibitor molecule ANGPTL4, nephrotic syndrome results in a marked decrease in abundance and activity in muscle and adipose tissue.
 Kidney International2 days ago

Findings from University of Kentucky Has Provided New Data on Cardiovascular Research (Defining the Role of PCSK9 Inhibitors in the Treatment of...

Findings from University of Kentucky Has Provided New Data on Cardiovascular Research (Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia) By a News Reporter-Staff News Editor at Clinical Trials Week Researchers detail new ...
 Pharmacy Choice3 days ago Findings from Hartford Hospital Has Provided New Data on Heart Disease [Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant...  Pharmacy Choice3 days ago Findings from University Hospital Provides New Data on Acute Coronary Syndrome (Prognostic value of PCSK9 levels in patients with acute coronary...  Pharmacy Choice1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less